TODD STRATEGY GROUP

Lobbying for ILLUMINA, INC. · Biotechnology company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 3

Health Issues

General discussions related to FDA regulation of diagnostics.

Medicare/Medicaid

General discussions related to Medicare reimbursement for diagnostic tests.

Trade (domestic/foreign)

General trade issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.